Secondary HIV Prevention and Adherence Among HIV-infected Drug Users
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01741311|
Recruitment Status : Recruiting
First Posted : December 4, 2012
Last Update Posted : September 13, 2017
University of Connecticut
National Institute on Drug Abuse (NIDA)
APT Foundation, Inc.
Information provided by (Responsible Party):
Michael Copenhaver, University of Connecticut
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Recruiting|
|Estimated Primary Completion Date :||June 2018|
|Estimated Study Completion Date :||June 2018|
Avants SK, Margolin A, Usubiaga MH, Doebrick C. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy. J Subst Abuse Treat. 2004 Mar;26(2):67-78.